Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elvia Cuauro
Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening
Endocrine Abstracts
Related publications
Long-Term Treatment of Acromegaly and Gigantism With Octreotide (SMS 201-995)
Folia Endocrinologica Japonica
Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant
Journal of Clinical Endocrinology and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes
Change in Quality of Life in Patients With Acromegaly After Treatment With Octreotide LAR: First Application of AcroQoL in Korea
BMJ Open
Medicine
Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
A Comparison Between Octreotide-Lar and Lanreotide-Sr in the Chronic Treatment of Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Case Study of a 15-Year-Old Boy With McCune-Albright Syndrome Combined With Pituitary Gigantism: Effect of Octreotide-Long Acting Release (LAR) and Cabergoline Therapy
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Differing Effects on Gall-Bladder Motility of Lanreotide SR and Octreotide LAR for Treatment of Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors
Oncologist
Cancer Research
Medicine
Oncology
Treatment of Recurrent Gastrointestinal Haemorrhage in a Patient With Von Willebrand's Disease With Octreotide LAR and Propranolol
Gut
Gastroenterology
